Bone health and skeletal fragility in second- and third-line medical therapies for acromegaly: preliminary results from a pilot single center experience Sabrina ChiloiroAntonella GiampietroAntonio Bianchi Letter 07 May 2024
Hypopituitarism and bone disease: pathophysiology, diagnosis and treatment outcomes Amit AkirovYaron RudmanMaria Fleseriu ReviewPaper 06 May 2024
The diagnosis and prevalence of hypoprolactinemia in patients with panhypopituitarism and the effects on depression and sexual functions Ilknur UzunZuleyha KaracaFahrettin Kelestimur OriginalPaper Open access 03 May 2024
Quality of life in Prolactinoma: A systematic review Mendel Castle-KirszbaumNienke BiermaszTony Goldschlager OriginalPaper Open access 24 April 2024
Changes in multi-modality management of acromegaly in a tertiary centre over 2 decades V. AmodruN. SahakianF. Castinetti OriginalPaper 23 March 2024
Prolactin-secreting tumors, dopamine agonists and pregnancy: a longitudinal experience of a tertiary neuroendocrine center Nunzia PrencipeChiara BonaSilvia Grottoli OriginalPaper Open access 18 March 2024
Pituitary tumours without distinct lineage differentiation express stem cell marker SOX2 Nèle F. LendersTanya J. ThompsonAnn I. McCormack OriginalPaper Open access 14 March 2024
Correction: Impulse control disorders in patients with dopamine agonist-treated pituitary adenomas: a cross-sectional multicenter study Mussa H. AlmalkiMoayad A. AlsuraikhAishah Ekhzaimy Correction 13 March 2024 Pages: 238 - 238
Glucose intolerance in acromegaly is driven by low insulin secretion; results from an intravenous glucose tolerance test Laura Georgiana ZaifuDan Alexandru NiculescuCatalina Poiana OriginalPaper 21 February 2024 Pages: 178 - 186
Elevated risk of recurrence and retreatment for silent pituitary adenomas Saksham GuptaSamantha E. HoffmanEdward R. Laws OriginalPaper 12 February 2024 Pages: 204 - 212
Impulse control disorders in patients with dopamine agonist-treated pituitary adenomas: a cross-sectional multicenter study Mussa H. AlmalkiMoayad A. AlsuraikhAishah Ekhzaimy OriginalPaper 12 February 2024 Pages: 197 - 203
Different patient versus provider perspectives on living with Cushing’s disease Amanda HalstromI.-Hsin LinEliza B. Geer OriginalPaper Open access 05 February 2024 Pages: 141 - 150
Pituitary hypophysitis in granulomatosis with polyangiitis (GPA): a case series Majid AlameriAbdulla AlnuaimiFlorian Wernig OriginalPaper Open access 31 January 2024 Pages: 230 - 237
Successful treatment of medically and surgically refractory lymphocytic hypophysitis with fractionated stereotactic radiotherapy: a single-center experience and systematic literature review Mehdi KhaleghiGuilherme FingerDaniel Prevedello OriginalPaper 25 January 2024 Pages: 213 - 229
Diffusion-weighted imaging does not seem to be a predictor of consistency in pituitary adenomas Monique Alvares BarbosaEduardo Giardini Rodovalhe PereiraMonica R. Gadelha OriginalPaper 25 January 2024 Pages: 187 - 196
Basal cortisol in relation to metyrapone confirmation in predicting adrenal insufficiency after pituitary surgery Pieter E. HuismanSarah E. SiegelaarEveline Bruinstroop OriginalPaper Open access 19 January 2024 Pages: 151 - 159
A medical chart audit to assess endocrinologist perceptions of the burden of endogenous Cushing’s syndrome Gabrielle Page-WilsonBhagyashree OakEliza B. Geer ReviewPaper Open access 08 January 2024 Pages: 129 - 140
Current status of artificial intelligence technologies in pituitary adenoma surgery: a scoping review Seyed Farzad MaroufiYücel DoğruelPaolo Palmisciano ReviewPaper 06 January 2024 Pages: 91 - 128
Prediction of adrenal insufficiency after pituitary surgery: a retrospective study using beckman access cortisol assay Maria Francesca BirtoloEmma GianniniAndrea G. Lania OriginalPaper 03 January 2024 Pages: 160 - 168
Correction: incidence of postoperative hyponatremia after endoscopic endonasal pituitary transposition for skull base pathologies Francesca GalbiatiSharini VenugopalHussain Mahmud Correction 30 December 2023 Pages: 89 - 90
Acromegaly increases depressive symptoms and reduces quality of life of cohabitants Serhat UysalCem SuluPinar Kadioglu OriginalPaper 30 December 2023 Pages: 169 - 177
Pituitary apoplexy score, toward standardized decision-making: a descriptive study Henri SalleMathilde CaneLaurence Salle OriginalPaper 27 December 2023 Pages: 77 - 87
Idiopathic isolated adrenocorticotropic hormone deficiency: a systematic review of a heterogeneous and underreported disease E. Van MieghemC. De BlockC. De Herdt ReviewPaper 27 December 2023 Pages: 23 - 32
Cabergoline treatment for surgery-naïve non-functioning pituitary macroadenomas Irit Ayalon-DangurAdi TurjemanIlan Shimon OriginalPaper 08 December 2023 Pages: 52 - 60
The prevalence and associated risk factors of detectable renal morphological abnormalities in acromegaly Hayri BostanMuhammed KizilgulErman Cakal OriginalPaper 08 December 2023 Pages: 44 - 51
Correction: consensus on criteria for acromegaly diagnosis and remission Andrea GiustinaNienke BiermaszAcromegaly Consensus Group Correction Open access 06 December 2023 Pages: 88 - 88
Incidence of postoperative hyponatremia after endoscopic endonasal pituitary transposition for skull base pathologies Francesca GalbiatiSharini VenugopalHussain Mahmud OriginalPaper 25 November 2023 Pages: 70 - 76
Newer parameters of the octreotide test in patients with acromegaly Shin UraiMasaaki YamamotoWataru Ogawa OriginalPaper 24 November 2023 Pages: 33 - 43
Symptoms and steroid dose adjustments following the Covid-19 vaccine in patients with adrenal insufficiency David S. McLarenGrace CroweRobert D. Murray OriginalPaper 17 November 2023 Pages: 61 - 69
Consensus on criteria for acromegaly diagnosis and remission Andrea GiustinaNienke BiermaszAcromegaly Consensus Group OriginalPaper Open access 03 November 2023 Pages: 7 - 22
Assessment of forearm muscles with ultrasound shear wave elastography in patients with acromegaly Meric CoskunHalit Nahit SendurFusun Balos Toruner OriginalPaper 30 October 2023 Pages: 716 - 724
Metastases to the pituitary gland: insights from the German pituitary tumor registry Linus HaberboschSimone SchmidChristian J. Strasburger OriginalPaper Open access 30 October 2023 Pages: 708 - 715
Correction: Care trajectories of surgically treated patients with a prolactinoma: why did they opt for surgery? Victoria R. van TrigtIngrid M. ZandbergenNienke R. Biermasz Correction Open access 28 October 2023 Pages: 725 - 728
Endoscopic endonasal marsupialization of rathke cleft cysts: clinical outcomes and risk factors analysis of visual impairment, pituitary dysfunction, and CSF leak Mohammad Bilal AlsavafKyle C. WuDaniel M. Prevedello OriginalPaper 25 October 2023 Pages: 696 - 707
The impact of facility type and volume on treatment and overall survival in craniopharyngioma Benjamin F. BitnerDerek H. LiuEdward C. Kuan OriginalPaper 17 October 2023 Pages: 686 - 695
Clinical characteristics and therapeutic outcomes of acromegalic patients with giant growth hormone-secreting pituitary adenomas: a single-center study of 67 cases Meiping ChenLian DuanHuijuan Zhu OriginalPaper 17 October 2023 Pages: 675 - 685
Reported baseline variables in transsphenoidal surgery for pituitary adenoma over a 30 year period: a systematic review Hugo Layard HorsfallRyan T. S. LohAngelos G. Kolias OriginalPaper Open access 16 October 2023 Pages: 645 - 652
Growth hormone insensitivity and adipose tissue: tissue morphology and transcriptome analyses in pigs and humans Jonathan A. YoungArne HinrichsDarlene E. Berryman OriginalPaper 25 September 2023 Pages: 660 - 674
Clinical and prognostic significance of granulation patterns in somatotroph adenomas/tumors of the pituitary: a meta-analysis Huy Gia VuongIan F. Dunn ReviewPaper 21 September 2023 Pages: 653 - 659
Anterior-posterior diameter is a key driver of resectability and complications for pituitary adenomas with suprasellar extension in endoscopic transsphenoidal surgery Jung ParkDanielle GolubAmir R. Dehdashti OriginalPaper 15 September 2023 Pages: 629 - 641
Pituitary metastases: a case series and scoping review Kaiyun YangSabrina L. BegleyPaul N. Kongkham OriginalPaper 12 September 2023 Pages: 538 - 550
Clinico-radiological correlation of pituitary stalk interruption syndrome in children with growth hormone deficiency Subbiah SridharBhagadurshah Rameez RajaVasanthiy Natarajan OriginalPaper 11 September 2023 Pages: 622 - 628
Care trajectories of surgically treated patients with a prolactinoma: why did they opt for surgery? Victoria R. van TrigtIngrid M. ZandbergenNienke R. Biermasz OriginalPaper Open access 10 September 2023 Pages: 611 - 621
Pituitary Tumor Centers of Excellence (PTCOE) should now include neuro-oncologic input E. JouanneauF CalvaneseG. Raverot Letter 07 September 2023 Pages: 642 - 643
Neuromedin B receptor as a potential therapeutic target for corticotroph adenomas Tomonori SekizakiHiraku KamedaTatsuya Atsumi OriginalPaper 29 August 2023 Pages: 597 - 610
Pilot study to define criteria for Pituitary Tumors Centers of Excellence (PTCOE): results of an audit of leading international centers A. GiustinaM. M. UygurF. F. Casanueva OriginalPaper Open access 28 August 2023 Pages: 583 - 596
Giant prolactinomas, a detailed analysis of 196 adult cases Billion LisaVerleye ArnoDe Herdt Carlien ReviewPaper 07 August 2023 Pages: 529 - 537
Changing presentation of acromegaly in half a century: a single-center experience Ahmet Numan DemirCem SuluPinar Kadioglu OriginalPaper 31 July 2023 Pages: 573 - 582